Drug combination slows colon cancer

A cholesterol-reducing drug combined with an anti-inflammatory drug similar to aspirin can slow the development of colorectal cancer in rats.

References:

Agarwal, B., et al. 1999. Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effect of sulindac. Meeting of the American Association for Cancer Research. April. Philadelphia.

Sources:

Banke Agarwal
St. Luke's-Roosevelt Hospital Center
1000 Tenth Avenue
New York, NY 10019

From Science News, Vol. 155, No. 17, April 24, 1999, p. 271. Copyright © 1999, Science Service.

• Home
• Search
• Feedback

• Table of Contents
• Online Archive
• Order Back Issues

• Science News Books
• Subscribe
• Address Changes